Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation.

Subramanian V, Ramachandran S, Banan B, Bharat A, Wang X, Benshoff N, Kreisel D, Gelman AE, Mohanakumar T.

Am J Transplant. 2014 Oct;14(10):2359-66. doi: 10.1111/ajt.12908. Epub 2014 Sep 12.

2.

Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.

Takenaka M, Subramanian V, Tiriveedhi V, Phelan D, Hachem R, Trulock E, Gelman AE, Patterson GA, Hoshinaga K, Mohanakumar T.

J Heart Lung Transplant. 2012 Nov;31(11):1214-22. doi: 10.1016/j.healun.2012.08.011. Epub 2012 Sep 11.

3.

Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.

Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M, Steward N, Aloush A, Hachem R, Trulock E, Meyers B, Patterson GA, Mohanakumar T.

J Heart Lung Transplant. 2011 Jun;30(6):624-31. doi: 10.1016/j.healun.2011.01.708. Epub 2011 Mar 16.

4.

A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.

Tiriveedhi V, Angaswamy N, Brand D, Weber J, Gelman AG, Hachem R, Trulock EP, Meyers B, Patterson G, Mohanakumar T.

Clin Exp Immunol. 2012 Jan;167(1):158-68. doi: 10.1111/j.1365-2249.2011.04486.x.

5.

Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.

Basha HI, Ramachandran S, Tiriveedhi V, Takenaka M, Subramanian V, Nath DS, Benshoff N, Patterson GA, Mohanakumar T.

Transplantation. 2013 Jan 27;95(2):293-300. doi: 10.1097/TP.0b013e3182772244.

6.

Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Angaswamy N, Tiriveedhi V, Sarma NJ, Subramanian V, Klein C, Wellen J, Shenoy S, Chapman WC, Mohanakumar T.

Hum Immunol. 2013 Nov;74(11):1478-85. doi: 10.1016/j.humimm.2013.07.002. Epub 2013 Jul 19. Review.

7.

Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy.

Angaswamy N, Klein C, Tiriveedhi V, Gaut J, Anwar S, Rossi A, Phelan D, Wellen JR, Shenoy S, Chapman WC, Mohanakumar T.

Am J Transplant. 2014 Mar;14(3):685-93. doi: 10.1111/ajt.12592. Epub 2014 Jan 10.

8.

Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation.

Bharat A, Chiu S, Zheng Z, Sun H, Yeldandi A, DeCamp MM, Perlman H, Budinger GR, Mohanakumar T.

Am J Respir Cell Mol Biol. 2016 Oct;55(4):532-541.

9.

Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection.

Gunasekaran M, Sharma M, Hachem R, Bremner R, Smith MA, Mohanakumar T.

J Immunol. 2018 Apr 15;200(8):2535-2541. doi: 10.4049/jimmunol.1701587. Epub 2018 Feb 28.

10.

Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.

Fukami N, Ramachandran S, Saini D, Walter M, Chapman W, Patterson GA, Mohanakumar T.

J Immunol. 2009 Jan 1;182(1):309-18.

11.

Role of alloimmunity and autoimmunity in allograft rejection.

Banan B, Xu Z, Gunasekaran M, Mohanakumar T.

Clin Transpl. 2013:325-32.

12.

Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.

Tiriveedhi V, Gautam B, Sarma NJ, Askar M, Budev M, Aloush A, Hachem R, Trulock E, Myers B, Patterson AG, Mohanakumar T.

J Heart Lung Transplant. 2013 Aug;32(8):807-14. doi: 10.1016/j.healun.2013.06.003.

13.

B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway Disease.

Xu Z, Ramachandran S, Gunasekaran M, Nayak D, Benshoff N, Hachem R, Gelman A, Mohanakumar T.

Am J Transplant. 2016 Apr;16(4):1173-82. doi: 10.1111/ajt.13595. Epub 2016 Feb 4.

14.

Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity.

Chiu S, Fernandez R, Subramanian V, Sun H, DeCamp MM, Kreisel D, Perlman H, Budinger GR, Mohanakumar T, Bharat A.

J Immunol. 2016 Jul 1;197(1):51-7. doi: 10.4049/jimmunol.1502539. Epub 2016 May 18.

15.

Type V collagen modulates alloantigen-induced pathology and immunology in the lung.

Mares DC, Heidler KM, Smith GN, Cummings OW, Harris ER, Foresman B, Wilkes DS.

Am J Respir Cell Mol Biol. 2000 Jul;23(1):62-70.

PMID:
10873154
16.

Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.

Haque MA, Mizobuchi T, Yasufuku K, Fujisawa T, Brutkiewicz RR, Zheng Y, Woods K, Smith GN, Cummings OW, Heidler KM, Blum JS, Wilkes DS.

J Immunol. 2002 Aug 1;169(3):1542-9.

17.

A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.

Nath DS, Tiriveedhi V, Basha HI, Phelan D, Moazami N, Ewald GA, Mohanakumar T.

Transplantation. 2011 May 15;91(9):1036-43. doi: 10.1097/TP.0b013e318211d2f4.

18.

Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease.

Takenaka M, Tiriveedhi V, Subramanian V, Hoshinaga K, Patterson AG, Mohanakumar T.

PLoS One. 2012;7(8):e42370. doi: 10.1371/journal.pone.0042370. Epub 2012 Aug 10.

19.

CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation.

Bharat A, Fields RC, Steward N, Trulock EP, Patterson GA, Mohanakumar T.

Am J Transplant. 2006 Aug;6(8):1799-808.

20.

Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance.

Yasufuku K, Heidler KM, Woods KA, Smith GN Jr, Cummings OW, Fujisawa T, Wilkes DS.

Transplantation. 2002 Feb 27;73(4):500-5. Erratum in: Transplantation 2002 May 15;73(9):1529.

PMID:
11889419

Supplemental Content

Support Center